Pharma Lab CRO ApS — Credit Rating and Financial Key Figures
CVR number: 40729364
Søbyvej 11, 2650 Hvidovre
itmgtconsulting@gmail.com
tel: 24342655
Income statement (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Fiscal period length | 12 | 12 | 12 | 12 |
Net sales | ||||
Gross profit | 2 384.08 | -2 676.14 | - 632.55 | |
Wages and salaries | - 584.25 | |||
Social security expenses | -25.06 | |||
Employee benefit expenses | -1 584.11 | -1 700.80 | ||
Other operating expenses | -69.18 | |||
Total depreciation | -76.27 | - 135.92 | - 135.92 | |
EBIT | -76.27 | 1 774.78 | -4 465.35 | -2 469.26 |
Other financial income | 9.73 | |||
Other financial expenses | 258.66 | -12.21 | -19.03 | -1.66 |
Income from other inv. held as non-curr. assets | - 708.07 | |||
Pre-tax profit | - 525.68 | 1 762.56 | -4 484.37 | -2 461.19 |
Income taxes | 115.65 | - 399.77 | 2.64 | |
Net earnings | - 410.03 | 1 762.56 | -4 884.15 | -2 458.55 |
Assets (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Intangible assets total | ||||
Machinery and equipment | 543.66 | 407.75 | 271.83 | |
Tangible assets total | 543.66 | 407.75 | 271.83 | |
Other receivables | 78.28 | 85.58 | ||
Investments total | 78.28 | 85.58 | ||
Non-current other receivables | 78.28 | 78.28 | ||
Long term receivables total | 78.28 | 78.28 | ||
Inventories total | ||||
Current trade debtors | 57.62 | 6 173.06 | 1 050.64 | 11.18 |
Current amounts owed by group member comp. | 10 000.00 | 10 700.00 | 9 852.69 | 10 927.67 |
Current other receivables | 315.24 | 797.19 | 1 039.43 | |
Short term receivables total | 10 057.62 | 17 188.29 | 11 700.51 | 11 978.28 |
Cash and bank deposits | 2 348.21 | 918.01 | 236.55 | 2 516.27 |
Cash and cash equivalents | 2 348.21 | 918.01 | 236.55 | 2 516.27 |
Balance sheet total (assets) | 12 484.10 | 18 728.24 | 12 423.08 | 14 851.96 |
Equity and liabilities (kDKK)
2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|
Share capital | 40.00 | 40.00 | 40.00 | 40.00 |
Retained earnings | 820.06 | 410.03 | 2 172.99 | -2 711.16 |
Profit of the financial year | - 410.03 | 1 762.56 | -4 884.15 | -2 458.55 |
Shareholders equity total | 450.03 | 2 212.59 | -2 671.16 | -5 129.71 |
Non-current advances received | 12 000.00 | 16 400.00 | ||
Non-current liabilities total | 12 000.00 | 16 400.00 | ||
Advances received | 14 750.00 | 19 750.00 | ||
Current trade creditors | 123.88 | 42.46 | ||
Short-term deferred tax liabilities | 115.65 | 127.66 | ||
Other non-interest bearing current liabilities | 34.08 | 92.71 | 189.22 | |
Current liabilities total | 34.08 | 115.65 | 15 094.24 | 19 981.67 |
Balance sheet total (liabilities) | 12 484.10 | 18 728.24 | 12 423.08 | 14 851.96 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.